Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Depreciation & Amortization - Total (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed Depreciation & Amortization - Total for 6 consecutive years, with $8.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization - Total rose 13.49% year-over-year to $8.0 million, compared with a TTM value of $22.0 million through Dec 2025, up 7.85%, and an annual FY2024 reading of $26.4 million, up 22.94% over the prior year.
  • Depreciation & Amortization - Total was $8.0 million for Q3 2025 at Alignment Healthcare, up from $7.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $8.0 million in Q3 2025 and bottomed at $52000.0 in Q1 2024.
  • Average Depreciation & Amortization - Total over 5 years is $5.1 million, with a median of $4.9 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization - Total plummeted 98.94% in 2024, then surged 13348.08% in 2025.
  • Year by year, Depreciation & Amortization - Total stood at $4.1 million in 2021, then increased by 14.83% to $4.7 million in 2022, then increased by 25.33% to $5.8 million in 2023, then grew by 16.72% to $6.8 million in 2024, then rose by 17.29% to $8.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for ALHC at $8.0 million in Q3 2025, $7.0 million in Q2 2025, and $7.0 million in Q1 2025.